By 
The Zambia Medicines and Medical supplies Agency (ZAMMSA) says it has recorded a major increase in laboratory commodity availability, reaching a significant 70 percent stock availability in the past week.
The availability of Laboratory commodities at the ZAMMSA central warehouse has been hovering around the 50 to 55 percent mark since 2023 and for the very first time has increased to a remarkable feat of 70 percent.
ZAMMSA Senior Manager for Corporate Communications, Bradley Chingobe, highlighted this in a statement issued in Lusaka on Tuesday.
Chingobe stated that this milestone reflects ZAMMSA’s commitment to ensuring access to essential medical supplies, to be specific, in the realm of laboratory consumables and reagents.
“It is important to note that Laboratory products are essential for conducting various diagnostic tests across service delivery points in all spheres of the country,” he said.
Chingobe stated that the availability of the commodities make it seamless for healthcare professionals to diagnose and precisely guide on appropriate treatment decisions in the identification process of diseases and varied conditions that affect the Zambian populace.
Additionally, Chingobe said ZAMMSA had also recorded a substantial improvement in the availability of Hematology reagents.
“These crucial components that are instrumental in facilitating the smooth operation of laboratory machines, thereby enhancing the efficiency and effectiveness of diagnostic processes,” he stated.
Read More: Zambia receives over 20,000 vials of long-acting injectable HIV prevention medication
Chingobe expressed happiness that ZAMMSA’s streamlined procurement strategy and support from the cooperating partners had enabled the effective accessibility of the laboratory commodities.
He said this in turn had enabled ZAAMSA to effectively distribute Hematology products to all corners of the country through our last mile’s distribution exercise, ensuring that healthcare facilities across the nation have access to these vital resources.
“ZAMMSA is pleased to report that the current stock levels of laboratory products, including Hematology reagents and HIV testing kits currently are sitting at 100 percent,” Chingobe highlighted.
He said Biochemistry commodities are sitting at 79 percent and are sufficient enough to meet the demand for the next five months.
Chingobe assured that ZAMMSA remained committed in ensuring a sustained supply chain and procurements of essential medicines and medical supplies.
WARNING! All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express permission from ZAMBIA MONITOR.
Comments